Free Trial

P3 Health Partners (PIII) Competitors

P3 Health Partners logo
$8.84 -0.15 (-1.61%)
Closing price 03:58 PM Eastern
Extended Trading
$8.82 -0.02 (-0.17%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PIII vs. XGN, SERA, DCGO, EUDA, QIPT, CORBF, BNR, ATPC, BDSX, and BMGL

Should you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Exagen (XGN), Sera Prognostics (SERA), DocGo (DCGO), EUDA Health (EUDA), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), Burning Rock Biotech (BNR), Agape ATP (ATPC), Biodesix (BDSX), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry.

P3 Health Partners vs. Its Competitors

Exagen (NASDAQ:XGN) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

75.3% of Exagen shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 12.6% of Exagen shares are owned by company insiders. Comparatively, 17.8% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Exagen's average media sentiment score of 0.95 beat P3 Health Partners' score of 0.83 indicating that Exagen is being referred to more favorably in the media.

Company Overall Sentiment
Exagen Positive
P3 Health Partners Positive

Exagen has higher earnings, but lower revenue than P3 Health Partners. Exagen is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exagen$58.86M4.31-$15.11M-$0.89-12.97
P3 Health Partners$1.50B0.04-$135.85M-$46.01-0.19

Exagen presently has a consensus target price of $12.60, indicating a potential upside of 9.19%. P3 Health Partners has a consensus target price of $16.25, indicating a potential upside of 83.93%. Given P3 Health Partners' higher possible upside, analysts clearly believe P3 Health Partners is more favorable than Exagen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exagen
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.78
P3 Health Partners
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Exagen has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500.

P3 Health Partners has a net margin of -9.99% compared to Exagen's net margin of -28.85%. Exagen's return on equity of -130.38% beat P3 Health Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Exagen-28.85% -130.38% -34.69%
P3 Health Partners -9.99%-183.60%-17.83%

Summary

Exagen beats P3 Health Partners on 9 of the 15 factors compared between the two stocks.

Get P3 Health Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PIII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PIII vs. The Competition

MetricP3 Health PartnersMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$63.52M$2.20B$6.08B$10.54B
Dividend YieldN/AN/A5.73%4.78%
P/E Ratio-0.1939.7184.6327.10
Price / Sales0.0412.66605.70131.13
Price / CashN/A65.0637.8662.13
Price / Book0.8412.2912.246.58
Net Income-$135.85M-$65.79M$3.32B$276.75M
7 Day Performance-3.97%0.97%0.76%0.92%
1 Month Performance2.02%8.09%8.03%4.21%
1 Year Performance-63.11%31.26%71.14%37.89%

P3 Health Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PIII
P3 Health Partners
2.9756 of 5 stars
$8.84
-1.6%
$16.25
+83.9%
-52.4%$63.52M$1.50B-0.19500
XGN
Exagen
4.1089 of 5 stars
$11.04
+0.8%
$12.00
+8.7%
+318.9%$240.94M$55.64M-12.40220Analyst Forecast
SERA
Sera Prognostics
0.9318 of 5 stars
$3.07
+0.3%
N/A-58.0%$115.28M$80K-3.61120News Coverage
DCGO
DocGo
1.6746 of 5 stars
$1.27
+10.4%
$3.24
+154.9%
-64.1%$112.48M$616.55M-6.684,407News Coverage
EUDA
EUDA Health
0.4756 of 5 stars
$3.36
+17.5%
N/A-14.3%$106.27M$4.01M0.002Positive News
Analyst Forecast
Short Interest ↑
Gap Up
QIPT
Quipt Home Medical
2.244 of 5 stars
$2.43
+0.8%
$3.15
+29.6%
-19.7%$104.70M$245.91M-10.121,200Short Interest ↑
Gap Up
CORBF
Global Cord Blood
N/A$0.75
flat
N/AN/A$91.16M$196.12M0.001,200
BNR
Burning Rock Biotech
1.0185 of 5 stars
$8.59
+2.8%
N/A+174.1%$89.96M$70.67M-4.521,390
ATPC
Agape ATP
0.7084 of 5 stars
$1.23
+7.9%
N/A-23.0%$57.01M$1.32M-3.0040Positive News
High Trading Volume
BDSX
Biodesix
3.5687 of 5 stars
$7.40
+1.1%
$32.50
+339.2%
-79.1%$53.67M$71.32M-1.28220Positive News
BMGL
Basel Medical Group
N/A$1.52
-7.3%
N/AN/A$30.27MN/A0.0036Gap Down

Related Companies and Tools


This page (NASDAQ:PIII) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners